FTC Declares Victory in Generic Drug Case

June 17 (Bloomberg) -- Drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Eli Lilly CEO Ricks Says AHCA Won't Hurt Drug Prices
43:20 - David Ricks, president and chief executive officer at Eli Lilly, and Indiana Governor Eric Holcomb discuss how changes to U.S. health coverage under the American Health Care Act may impact drug pricing and access to coverage for citizens. They speak on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Bechtel Sees Short-Term Dollar Negative If AHCA Fails
  • EU's Juncker Says U.K. Brexit Bill May Hit $62 Billion
  • Carson Block Says 'Never a Great Time' to Be Short Seller